Détention brevets de la classe A61K 31/56

Brevets de cette classe: 2917

Historique des publications depuis 10 ans

213
212
194
184
190
190
126
111
114
97
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Propriétaires principaux

Proprétaire
Total
Cette classe
The Regents of the University of California
20268
56
Sage Therapeutics, Inc.
374
29
The Johns Hopkins University
5752
28
Mexichem Fluor, Sociedad Anonima de Capital Variable
204
22
Ellodi Pharmaceuticals, L.P., General Partner, Ellodi Development I Genpar, LLC, a Delaware limited liability company
28
22
Brigham Young University
600
21
InterCept Pharmaceuticals, Inc.
202
20
Emory University
1653
19
Lipocine Inc.
115
19
Reata Pharmaceuticals, Inc.
118
19
Corcept Therapeutics, Inc.
353
17
Laboratoire Hra-pharma
153
16
Arven Ilac Sanayi Ve Ticaret A.S.
95
15
Enanta Pharmaceuticals, Inc.
433
15
Phoenix Biotechnology, Inc.
48
15
Alcon, Inc.
5511
13
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
840
13
Board of Regents, The University of Texas System
5927
12
Royalty Security, LLC
20
12
California Institute of Technology
3989
11
Autres propriétaires 2523